Eventide Asset Management »

Ovid Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.0M 4.3M 1.63

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics